New Delhi | ANI: US Deputy Secretary of State Wendy Sherman on Friday underscored the importance of India's role as a global Covid vaccine producer and applauded New Delhi's announcement to resume vaccine exports.
Taking to Twitter, Sherman said that India is a crucial global leader in the fight against COVID-19. "As the world's largest vaccine producer, India is a crucial global leader in the fight against COVID-19. We welcomed Prime Minister @narendramodi's participation in the Global COVID-19 Summit during #UNGA and applaud India's announcement to resume vaccine exports," Sherman tweeted.
As the world’s largest vaccine producer, India is a crucial global leader in the fight against COVID-19. We welcomed Prime Minister @narendramodi's participation in the Global COVID-19 Summit during #UNGA and applaud India’s announcement to resume vaccine exports. pic.twitter.com/eM0YET8J7T— Wendy R. Sherman (@DeputySecState) October 15, 2021
This comes as India has resumed the supply of COVID-19 vaccines along with initial supplies in this round to the neighbourhood. It is learnt that India has recently sent Covid vaccines to Iran, Myanmar, Nepal and Bangladesh.
Both Bangladesh and Iran each received one million doses of "Made-in-India" vaccines. -in-India COVID-19 vaccines are in huge demand especially in the neighbourhood, it is learnt that during several diplomatic engagements, the majority of south Asian neighbours had time and again urged India to restart the export of vaccines.
India had to freeze its "Vaccine Maitri" program in early May this year as the country was severely hit by a deadly second wave of the COVID-19. It is the last month India announced that it is reopening the export of Covid vaccines.
India's decision to reopen exports of vaccines is welcomed by the International community. Quad, the United States and countries of the European Union (EU) appreciated India's move. India's step to open vaccine supplies is a major boost to the world in general and South Asia in particular.
Meanwhile, The head of the US International Development Finance Corporation would be visiting India later this month as part of the Quad's efforts to boost vaccine manufacturing. Leading a high-powered delegation, DFC Chief Operating Officer (COO) David Marchick would travel to India from October 24 to 26.
In Hyderabad, the delegation will visit the offices of the Indian vaccine manufacturer Biological E and participate in a signing ceremony to open a new facility with substantial capacity for vaccine manufacturing, an official release said.
Posted By: Mallika Mehzabeen